Arbutus Biopharma Corp·4

Jun 1, 5:03 PM ET

HENRIQUES RICHARD C JR 4

4 · Arbutus Biopharma Corp · Filed Jun 1, 2020

Insider Transaction Report

Form 4
Period: 2020-05-28
Transactions
  • Award

    Stock Options

    2020-05-28+22,00022,000 total
    Exercise: $2.16From: 2020-05-28Exp: 2030-05-28Common Stock (22,000 underlying)
Footnotes (2)
  • [F1]Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on May 28, 2020, the date of the grant.
  • [F2]The options are fully vested and exercisable as of the date of the grant.

Documents

2 files